Walder Wyss has acted as Swiss counsel to CRISPR

CRISPR Therapeutics announced subsequent sales under the Open Market Sale AgreementSM with Jefferies LLC (Jefferies), under which CRISPR may offer and sell, from time to time at its sole discretion through Jefferies (as its sales agent), common shares having an aggregate offering price of up to USD 350 million. The sales will be made by any method that is deemed an “at the market offering” (ATM) under the US Securities Act.

The team

Walder Wyss has acted as Swiss counsel to CRISPR in connection with the transaction. The team is being led by Alex Nikitine (Partner, Corporate/M&A, Capital Markets – pictured) and further includes Rafael Zemp (Managing Associate, Corporate/M&A, Capital Markets), Christian Lütolf (Managing Associate, Corporate/M&A), Maurus Winzap (Partner, Tax) and Janine Corti (Counsel, Tax).

Walder Wyss has acted as Swiss counsel to CRISPR

FabioAdmin

Legalcommunity.ch

Launched in 2020 by LC Publishing Group, it is the first digital portal addressed to the Swiss legal market.
In terms of contents, the website focuses on both law firms and in-house legal departments, covering the latest news and rumors on deals and operations (and the related advisors) as well as on lateral hires, moves and new appointments and providing insights, analytical data and opinions on the professions’ main trends and topics (Ai, innovation, etc.).

For further information, please visit the Group’s website www.lcpublishinggroup.com

LC Publishing Group S.p.A. – Via Tolstoi 10 – 20146 Milano – Tel. 0236727659 – C.F./P.IVA 07619210961
REA 1971432 Registro delle Imprese di Milano – Cap. Soc. Euro 50.000,00 i.v.

Copyright 2022 © All rights Reserved. Design by Origami Creative Studio

SHARE

Share on linkedin
Share on twitter
Share on facebook
Share on whatsapp
Share on email
Share on telegram